Add Yahoo as a preferred source to see more of our stories on Google. Is it flu season yet? Not quite. Flu season typically runs from October to May, with activity peaking during the colder months. It ...
Walgreens has agreed to be taken private for $11.45 per share. The deal has been approved by shareholders, and the stock is trading for slightly more than the takeover price. There's a nuance to the ...
Walgreens is now a $10 billion private equity prize, and the first big move after that windfall has been to squeeze the people who keep its stores running. Instead of translating that massive deal ...
Walgreens recently announced hundreds of store closings — but no retail stores are marked for closure yet in Illinois. A Walgreens specialty pharmacy at a clinic in Chicago's Lakeview neighborhood is ...
The pharmacy and retail store now counts itself as one of thousands of portfolio companies owned by private equity, an industry renowned for its profits-first, people-last approach to business.
News that Walgreens Boots Alliance quarterly loss was better than expected and pharmacy sales are rising bodes well for a financial turnaround under new private equity ownership. Under future owner ...
Add Yahoo as a preferred source to see more of our stories on Google. The Walgreens store at 771 Centre St. in Brockton is set to permanently close in five weeks. According to the company's website, ...
Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. The company has not been performing particularly well for the last few years. While there's a ...
Walgreens announced the closure of several stores in suburban Philadelphia, including a Southampton location, as it continues to struggle with sluggish consumer spending, with 500 stores set to ...
Four now-vacant Walgreens pharmacies around Colorado Springs could see new logos aglow in their large lit window facades in the coming years. But what is a good fit for the former stand-alone ...
Walgreens Boots Alliance (NASDAQ: WBA) has been a difficult stock to love for a few years, thanks to multiple corporate missteps. It got so bad that the board decided the best course of action was to ...